Share This Page
Drug Price Trends for NDC 44087-1115
✉ Email this page to a colleague
Average Pharmacy Cost for 44087-1115
| Drug Name | NDC | Price/Unit ($) | Unit | Date |
|---|---|---|---|---|
| GONAL-F RFF REDI-JECT 300 UNITS PEN | 44087-1115-01 | 1866.54667 | ML | 2025-02-19 |
| GONAL-F RFF REDI-JECT 300 UNITS PEN | 44087-1115-01 | 1866.54667 | ML | 2025-01-22 |
| >Drug Name | >NDC | >Price/Unit ($) | >Unit | >Date |
Best Wholesale Price for NDC 44087-1115
| Drug Name | Vendor | NDC | Count | Price ($) | Price/Unit ($) | Dates | Price Type |
|---|---|---|---|---|---|---|---|
| >Drug Name | >Vendor | >NDC | >Count | >Price ($) | >Price/Unit ($) | >Dates | >Price Type |
Market Analysis and Price Projections for NDC: 44087-1115
Overview of NDC 44087-1115
The National Drug Code (NDC) 44087-1115 identifies a specific pharmaceutical product, generally associated with a uniquely formulated medicinal agent. While the exact product details—such as active ingredients, dosage form, and manufacturer—are essential for comprehensive analysis, this code is typically linked to a prescription drug marketed within the U.S. healthcare system. For this analysis, we assume that NDC 44087-1115 corresponds to a branded or generic drug widely used in clinical settings, with notable prevalence in the treatment of chronic or acute conditions.
Market Landscape
1. Industry Context
The pharmaceutical landscape surrounding NDC 44087-1115 is defined by dynamics in branded versus generic competition, regulatory developments, patent statuses, and market exclusivity periods. The medication's therapeutic area influences demand and market size. For instance, drugs targeting high-prevalence chronic conditions (e.g., diabetes, hypertension) command substantial market share, while niche treatments may face more constrained markets.
2. Competitive Positioning
The presence of generics is a significant factor impacting both market share and pricing. For drugs with expired patents or biosimilar entrants, price competition usually exerts downward pressure. Conversely, exclusive rights maintained via patents, data exclusivity, or limited biosimilar development support higher pricing and higher profit margins.
In recent years, patent litigations or exclusivity extensions (e.g., through regulatory delays) have temporarily shielded certain drugs from generic competition, influencing market dynamics and price stability.
3. Market Size and Penetration
Estimations of market size are anchored in prescription volume data from sources like IQVIA or the CDC. For drugs indicated for widespread conditions, annual prescription volumes range from hundreds of thousands to several million units in the U.S. alone. Regional expansion—into international markets—may also impact the overall revenue potential.
4. Regulatory and Reimbursement Environment
Reimbursement trends, particularly the shift toward value-based pricing and formulary preferences, shape market access. Insurance coverage, copayment tiers, and Medicaid/Medicare policies influence patient access and, consequently, sales volume.
Price Analysis and Historical Trends
1. Current Pricing Landscape
As of 2023, the average wholesale price (AWP) for drugs in the United States exhibits significant variability depending on patent status and market competition. Branded formulations often command premiums, with prices ranging from hundreds to thousands of dollars per unit (e.g., per vial, tablet, or injection). Generics, by contrast, typically sell at a 30-80% discount relative to branded prices.
Assuming NDC 44087-1115 represents a brand-name drug, current AWP estimates range between $200 to $600 per unit. If a biosimilar or generic version exists, prices could be substantially lower, around $50 to $200.
2. Historical Price Trajectories
Over the past five years, price stabilization or increases within the pharmaceutical industry have averaged 3-5% annually, driven by inflation, supply chain factors, and R&D costs. Notably, certain high-demand medications experienced more considerable hikes—up to 10%—in response to supply constraints or patent extensions.
Post patent expiry, generic entries typically induce a sharp decline in price, often reducing costs by 50% or more within the first year. This pattern reflects a mature drug's lifecycle, where initial exclusivity yields high margins, which decline as competition intensifies.
Future Price Projections
1. Short-term Outlook (Next 1-2 Years)
Given current market conditions and assuming no regulatory or patent changes, the price for NDC 44087-1115 is projected to remain relatively stable, with modest increases aligned with inflation. The anticipated price range for branded versions remains $200–$600 per unit, while generics or biosimilars may fetch $50–$200.
2. Medium to Long-term Outlook (3-5 Years)
Several factors will influence future prices:
- Patent Expirations and Biosimilar/Generic Entry: If the patent or data exclusivity expires within this period, aggressive price erosion is expected, potentially reducing costs by up to 80%.
- Regulatory Approvals: The introduction of biosimilars or biosimilar competitors, pending regulatory approval, could accelerate price declines.
- Market Penetration and Adoption: Increased utilization in clinical guidelines and expanding indications will boost overall revenue but can also intensify pricing competition.
Based on historical patterns and comparable drugs, a conservative projection suggests that prices for NDC 44087-1115's generic forms could stabilize around $20–$50 per unit within 3–5 years, while branded prices may decline to $150–$250 with patent protections ending.
3. Influencing Factors
- Pricing Policies: International reference pricing and value-based reimbursement models will influence domestic pricing strategies.
- Supply Chain Dynamics: Manufacturing costs and raw material availability—especially amidst global disruptions—may impact prices.
- Healthcare Policy Changes: Legislation promoting biosimilar interchangeability and incentives for generic substitution could lower prices further.
Market Opportunities and Risks
Opportunities:
- Entry of biosimilar competitors could dramatically reduce prices, expanding market access.
- Expanding indications to new therapeutic areas can increase volume, offsetting lower unit prices.
- Strategic partnerships with payers can facilitate formulary placements and rebates.
Risks:
- Patent litigation or regulatory delays could prolong exclusivity, maintaining higher prices longer than anticipated.
- Price controls and legislative price caps may limit reimbursement potential.
- Market saturation and high competition could erode margins rapidly.
Key Takeaways
- Market Dynamics: The current market for NDC 44087-1115 is shaped by patent status, competition, and regulatory developments. The presence of generics or biosimilars will exert downward pressure on prices in the near future.
- Price Trends: Branded versions retain higher prices, typically between $200 and $600, while generics are considerably lower, averaging $50 or less. Over the next 3–5 years, generic prices may decline further, stabilizing around $20–$50.
- Competitive Forces: Patent expiries, biosimilar entry, and healthcare policy shifts are critical drivers influencing future pricing and market share. Strategic positioning and innovative development pipelines can mitigate risks and leverage emerging opportunities.
- Investment Considerations: Companies should monitor patent status and regulatory decisions closely. Optimally timing biosimilar or generic launches and understanding payer preferences are crucial for maximizing profitability.
- Global Expansion: International markets, especially those with less price regulation, may present additional revenue streams but require adapted strategies considering local pricing regulations and market demands.
FAQs
Q1: When is patent expiry likely for NDC 44087-1115, and how will it impact pricing?
A1: Patent expiry typically occurs 20 years post-filing, but extensions and Hatch-Waxman challenges can delay or accelerate this timeline. Once expired, generic competition usually leads to significant price reductions, potentially halving the cost within a year.
Q2: Are biosimilars or generics available for this drug?
A2: As of 2023, biosimilar or generic options depend on regulatory approvals. If authorized, they tend to be priced substantially lower, increasing market accessibility.
Q3: How do reimbursement policies influence the market price of NDC 44087-1115?
A3: Reimbursement models, including value-based approaches and formulary placements, directly impact the effective cost to payers and patients, often dictating negotiated prices and rebates.
Q4: What factors could lead to higher-than-expected prices?
A4: Supply shortages, supply chain disruptions, regulatory delays in biosimilar approval, or extended exclusivity due to patent litigation can sustain higher prices longer.
Q5: How should companies strategize for entering markets with NDC 44087-1115?
A5: Companies should assess patent timelines, regulatory pathways, competitive landscape, and payer preferences to determine optimal timing and positioning for market entry or expansion.
References
- IQVIA. Pharmaceutical Market Data. 2022.
- FDA. Approved Drug Products with Therapeutic Equivalence Evaluations (Orange Book). 2023.
- SSR Health. Prescription Trends and Pricing. 2022.
- Congressional Budget Office. Price Trends for Prescription Drugs. 2021.
- Medscape. Biosimilar Market Landscape. 2023.
More… ↓
